Professor
Department of Health Services
and Radiology
Director of Health Economics at RAND
E:mail: dana_goldman@rand.org

Dana Goldman holds the RAND Chair in Health Economics and is Director of Health Economics at RAND. He is also a Professor of Health Services and Radiology at UCLA. His research interests combine applied microeconomics and medical issues, with a special interest in the role that medical technology and health insurance play in determining health-related outcomes. His work has been published in leading medical, economic, statistics, and health policy journals with funding from both the public and private sectors, including the National Institutes of Health, National Institute on Aging, National Cancer Institute, National Science Foundation, Amgen, Merck, Genentech, California Healthcare Foundation, Smith Richardson Foundation, Department of Defense, Department of Labor, and the Agency for Healthcare Research and Quality. Most recently, he is the director of the RAND Roybal Center for Health Policy Simulation designed to provide better estimates of the impact of health policy changes. Dr. Goldman serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He was the recipient of the National Institute for Health Care Management Research Foundation award for excellence in health policy, and the Alice S. Hersh New Investigator Award that recognizes the outstanding contributions of a young scholar to the field of health services research. He is also a research associate with the National Bureau of Economic Research. Dr. Goldman received his B.A from Cornell University and a Ph.D. in Economics from Stanford University.

Selected Publications

Lakdawalla D, Sood N, Goldman D. “HIV Treatment and Risky Sexual Behavior.”
Quarterly Journal of Economics, forthcoming.

Goldman D, Smith J. “Socioeconomic Differences in the Adoption of New Medical Technologies.” American Economic Review Papers and Proceedings, 95(2):234-237, 2005.

Goldman D, Joyce G, et al. "Pharmacy Benefits and The Use Of Drugs By The Chronically-Ill.”
Journal of the American Medical Association, 291(19):2344-50, 2004.

Bhattacharya J, Goldman D, Sood N. “The Link Between Public and Private Insurance and HIV Related Mortality.” Journal of Health Economics, 22(6): 1105-1122, 2003.

Goldman D, Berry S, et al. “The Incremental Costs of NCI-Sponsored Clinical Trials.”
Journal of the American Medical Association, 289(22), 2003.

Joyce G, Escarce J, Solomon M, Goldman D. “Employer Drug Benefit Plans and Spending on Prescription Drugs.” Journal of the American Medical Association, 288(14):1733-1739, 2002.

Goldman D, Smith J. “Can Patient Self-Management Help Explain the SES Health Gradient?”
Proceedings of the National Academy of Sciences, 99(16):10929-10934, 2002.

Goldman D, Bhattacharya J, McCaffrey D, Duan N, Leibowitz A, Joyce G, Morton S. “The Effect of Insurance on Mortality in an HIV+ Population in Care.”
Journal of the American Statistical Association, 96(455):883-894, 2001.

Goldman D, Hosek S, Dixon L, Sloss E. “The Effects of Benefit Design and Managed Care on Health Care Costs.” Journal of Health Economics 14(4):401-418, 1995.

Goldman D. “Managed Care as a Public Cost Containment Mechanism.”
RAND Journal of Economics, 26(2):277-295, 1995.